[시장보고서]타겟 시퀀싱 시장 - 세계 및 지역별 분석 : 용도별, 제품 유형별, 표적 강화 방법별, 표적 캡처 유형별, 최종 사용자별, 지역별

타겟 시퀀싱 시장 - 세계 및 지역별 분석 : 용도별, 제품 유형별, 표적 강화 방법별, 표적 캡처 유형별, 최종 사용자별, 지역별 - 분석 및 예측(2024-2033년)

Targeted Sequencing Market - A Global and Regional Analysis: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Region - Analysis and Forecast, 2024-2033

상품코드 : 1458547

리서치사 : BIS Research

발행일 : 2024년 04월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

2023년 타겟 시퀀싱 시장 규모는 34억 7,980만 달러에 달했습니다.

이 시장은 예측 기간인 2024년부터 2033년까지 12.28%의 연평균 복합 성장률(CAGR)로 성장하여 2033년에는 109억 8,740만 달러에 달할 것으로 예상됩니다. 세계 타겟 시퀀싱 시장은 연구 이니셔티브 증가, 정밀의료에 대한 수요 증가, 주요 기업의 지리적 확장이 주요 요인으로 작용하고 있습니다.

주요 시장 통계
예측 기간	2024년-2033년
2024년 평가	38억 7,000만 달러
2033년 전망	109억 8,000만 달러
CAGR	12.28%

세계 타겟 시퀀싱 시장은 기존 기업들과 신생 기업들이 시장 점유율을 놓고 치열한 경쟁을 벌이고 있습니다. 시장의 예상 성장과 변화는 도전과 기회를 동시에 가져다주며, 향후 몇 년동안 역동적인 전망이 될 것으로 예상됩니다.

타겟 시퀀싱은 다양한 용도의 임상 현장에서 폭넓게 활용될 것으로 예상됩니다. 예를 들어, 질병의 조기 발견, 맞춤형 치료법 선택, 치료 반응 모니터링 등이 있습니다. 또한, 지속적인 가격 하락과 처리량 증가는 환자 수준에서 광범위한 채택을 촉진하고 있습니다. 타겟 시퀀싱 워크플로우의 자동화, 단일 세포 시퀀싱, 생물정보학의 발전, 액체 취급 및 핵산 준비에 대한 관심 증가는 타겟 시퀀싱 방법을 지속적으로 변화시킬 것으로 예상됩니다. 이 산업은 유전체학 및 정밀 진단에 의해 촉진되고 있습니다.

세계 타겟 시퀀싱 시장에 대해 조사했으며, 시장 개요와 함께 용도별/제품 유형별/타겟 강화 방법별/타겟 캡처 유형별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등을 정리하여 전해드립니다.

영문목차

Global Targeted Sequencing Market Overview

In 2023, the targeted sequencing market held a value of $3,479.8 million. The market is expected to grow at a CAGR of 12.28% during the forecast period 2024-2033 and attain a value of $10,987.4 million by 2033. The global targeted sequencing market is primarily driven by increasing research initiatives, rising demand for precision medicine, and geographical expansion of key players.

Market Lifecycle Stage

KEY MARKET STATISTICS
Forecast Period	2024 - 2033
2024 Evaluation	$3.87 Billion
2033 Forecast	$10.98 Billion
CAGR	12.28%

The global targeted sequencing market has been characterized by intense competition, as established entities and emerging players compete for a share of the market. The anticipated growth and transformation of the market bring forth both challenges and opportunities, which are expected to make it a dynamic landscape to observe in the upcoming years.

Industry Impact

Targeted sequencing is expected to be a period of wider adoption in clinical settings across various applications. For instance, use in early disease detection, personalized treatment selection, and monitoring treatment response. Additionally, continuous price reduction and higher throughput are driving the widespread adoption at the patient level. Increasing focus on automation in targeted sequencing workflows, single-cell sequencing, advancements in bioinformatics, liquid handling, and nucleic acid preparation are expected to continue to transform targeted sequencing methods. The industry is likely to witness the dynamic contributions of genomics and precision diagnostics.

The industry's advancements in targeted sequencing research and development continually address population health trends, disease prevalence, and treatment outcomes. As a result, the targeted sequencing market's impact extends beyond technological integration for diagnosis, making it an integral component of global health strategies and broader ecosystem.

Market Segmentation:

Segmentation 1: by Application

Cancer
Reproductive Health
Hereditary Diseases
Neurological Disorders
Infectious Diseases
Cardiovascular Diseases
Rare Diseases
Other Applications

Cancer to Dominate the Global Targeted Sequencing Market (by Application)

The cancer segment dominated the global targeted sequencing market (by application) in FY2023.

Targeted sequencing panels are rapidly becoming the standard of care in the management of patients with advanced cancer. NGS-based gene panel tests have successfully identified driver mutations in colorectal cancer, breast cancer, and lung cancers, which has subsequently resulted in the development and use of targeted therapies associated with improved outcomes.

Segmentation 2: by End User

Diagnostic and Clinical Laboratories
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Other End Users

Academic and Research Institutions to Dominate the Global Targeted Sequencing Market (by End User)

The academic and research institutions segment dominated the global targeted sequencing market (by end user) in FY2023.

Growing research initiatives undertaken by universities and research institutes in exploring new applications for targeted sequencing are driving the academic and research institutions segment growth.

Segmentation 3: by Product Type

Instruments
Services
Kits/Panels and Assays
Others

Services to Dominate the Global Targeted Sequencing Market (by Product Type)

The global targeted sequencing market (by product type) was dominated by the services segment in FY2023. This is largely due to the value proposition offered by targeted sequencing services. These services present an economically viable, efficient, and expertise-centric approach for laboratories and researchers.

Segmentation 4: by Target Enrichment Method

Hybridization Capture
Amplicon Sequencing
Other Target Enrichment Methods

Hybridization Capture to Dominate the Global Targeted Sequencing Market (by Target Enrichment Method)

The global targeted sequencing market (by target enrichment method) was dominated by the hybridization capture segment in FY2023. The hybridization capture-based method is more suitable for research and discovery projects. Therefore, scientists and clinicians tend to employ hybridization capture for large panels for the detection of SNPs, fusion genes, copy number variations (CNV), and others.

Segmentation 5: by Target Capture

Targeted DNA Sequencing
Targeted RNA Sequencing
Other Types of Target Capture

Targeted DNA Sequencing to Dominate the Global Targeted Sequencing Market (by Target Capture)

The global targeted sequencing market (by target capture) was dominated by the targeted DNA sequencing segment in FY2023. Targeted DNA sequencing allows researchers to focus time and expense on the data analysis of only the regions of interest.

Segmentation 6: by Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

The targeted sequencing market in the North America region has been witnessing significant growth of 12.39% in the forecast period, marked by increasing research and development in the region and early adoption of advanced technologies. In 2023, North America accounted for a share of 49.90% of the global targeted sequencing market.

Demand - Drivers, Restraints, and Opportunities

Market Drivers:

Increasing Demand for High Depth of Coverage in Sequencing: Increasing depth of coverage is a pivotal driving factor in the targeted sequencing market, as it directly influences the accuracy and reliability of genomic analyses.

Market Restraints:

Lack of Advanced Genomic Testing Centers: There is difficulty in establishing and maintaining different sequencing technology platforms, including their supportive genomic data analysis software tools, which also require maintenance in terms of upgrades.

Market Opportunities:

Increasing Opportunities in Early Diagnosis: With the rise in advancements in NGS, early diagnosis and gene editing have been more feasible with techniques such as targeted sequencing.

How can this report add value to an organization?

Workflow/Innovation Strategy: The targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the global targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

The base year considered for the calculation of the market size is 2023. The historical year analysis has been done from FY2020 to FY2022, and the market size has been calculated for FY2023 and projected for the period 2024-2033.
The geographical distribution of the market revenue is estimated to be the same as the company's net revenue distribution. All the numbers have been adjusted to two digits after decimals for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR has been calculated from 2024 to 2033.
The market has been mapped based on different types of products available in the market and several indications. All the key manufacturing companies that have a significant number of offerings to the targeted sequencing market have been considered and profiled in the report.
In the study, the primary respondents' verification was considered to finalize the estimated market for the targeted sequencing market.
The latest annual reports of each market player have been taken into consideration for market revenue calculation.
Market strategies and developments of key players have been considered for the calculation of sub-segment split.
The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website or from the annual reports of the respective company, if stated.

Primary Research

The key data points taken from the primary sources include:

Validation and triangulation of all the numbers and graphs
Validation of the report's segmentation and key qualitative findings
Understanding of the numbers of the various markets for market type
Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

Food and Drug Administration (FDA), PubMed, and National Center for Biotechnology Information (NCBI)
Annual reports, SEC filings, and investor presentations of the leading market players
Company websites and detailed study of their portfolio
Gold standard magazines, journals, whitepapers, press releases, and news articles
Databases

The key data points taken from the secondary sources include:

Segmentations, split-ups, and percentage shares
Data for market value
Key industry trends of the top players in the market
Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The global targeted sequencing industry is in a growth phase and constantly evolving. Illumina, Inc. holds a significant market share in terms of technology and consumables and is expected to retain its dominance. The market dominance can be attributed to its huge product portfolio and highly accurate sequencing instruments. Other established players in the market include PerkinElmer, Inc., Beijing Genomics Institute (BGI), Thermo Fisher Scientific, Inc., and Agilent Technologies, Inc.

Some of the prominent companies in this market are:

Agilent Technologies, Inc.
Azenta, Inc.
BGI Group
CD Genomics
F. Hoffmann-La Roche Ltd
Daicel Corporation
Thermo Fisher Scientific, Inc.
Danaher Corporation
Illumina, Inc.
LGC Limited
PacBio
Revvity, Inc.
Psomagen
QIAGEN N.V.
Takara Bio Inc.

Companies that are not a part of the aforementioned pool have been well-represented across different sections of the report (wherever applicable).

Executive Summary

Scope and Definition

1 Markets

1.1 Trends: Current and Future Impact Assessment
- 1.1.1 Increasing Number of Targeted Sequencing Products and Services in the Market
- 1.1.2 Increasing Synergistic Partnerships between Market Players
1.2 Targeted Sequencing Workflow
1.3 Research and Development Review
- 1.3.1 Patent Filing Trend (by Country, Year)
1.4 Regulatory Landscape
1.5 Market Dynamics: Overview
- 1.5.1 Market Drivers
  - 1.5.1.1 Increasing Demand for High Depth of Coverage in Sequencing
  - 1.5.1.2 Cost and Data Management Benefits of Targeted Sequencing as Compared to WGS
- 1.5.2 Market Restraints
  - 1.5.2.1 Lack of Advanced Genomic Testing Centers
  - 1.5.2.2 Lack of Knowledge about New Genes
- 1.5.3 Market Opportunities
  - 1.5.3.1 Increasing Use in Clinical Research and Trials for Better Disease Pathogenesis and/or Clinical Relevance
  - 1.5.3.2 Increasing Adoption in Targeted Therapeutics in Oncology

2 Application

2.1 Application Segmentation
2.2 Application Summary
- 2.2.1 Application Summary
- 2.2.2 End User Summary
  - 2.2.2.1 Analyst View
2.3 Targeted Sequencing Market (by Application)
- 2.3.1 Cancer
- 2.3.2 Infectious Diseases
- 2.3.3 Cardiovascular Diseases
- 2.3.4 Reproductive Health
- 2.3.5 Rare Diseases
- 2.3.6 Neurological Disorders
- 2.3.7 Hereditary Diseases
- 2.3.8 Other Applications
2.4 Targeted Sequencing Market (by End User)
- 2.4.1 Academic and Research Institutions
- 2.4.2 Pharmaceutical and Biotech Companies
- 2.4.3 Diagnostic and Clinical Laboratories
- 2.4.4 Other End Users

3 Products

3.1 Product Segmentation
3.2 Product Summary
- 3.2.1 Product Type Summary
- 3.2.2 Type of Target Capture Summary
- 3.2.3 Target Enrichment Methods Summary
3.3 Targeted Sequencing Market (by Product Type)
- 3.3.1 Services
- 3.3.2 Kits/Panels and Assays
- 3.3.3 Instruments
- 3.3.4 Others
3.4 Targeted Sequencing Market (by Target Enrichment Methods)
- 3.4.1 Amplicon Sequencing
- 3.4.2 Hybridization Capture
- 3.4.3 Microfluidic-Based Enrichment
- 3.4.4 Enzymatic Cleavage
3.5 Targeted Sequencing Market (by Type of Target Capture)
- 3.5.1 Targeted DNA Sequencing
- 3.5.2 Targeted RNA Sequencing
- 3.5.3 Other Types of Target Capture

4 Regions

4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
- 4.3.1 Regional Overview
  - 4.3.1.1 Driving Factors for Market Growth
  - 4.3.1.2 Factors Challenging the Market
- 4.3.2 Application
- 4.3.3 Product
- 4.3.4 U.S.
- 4.3.5 Application
- 4.3.6 Product
- 4.3.7 Canada
- 4.3.8 Application
- 4.3.9 Product
4.4 Europe
- 4.4.1 Regional Overview
  - 4.4.1.1 Driving Factors for Market Growth
  - 4.4.1.2 Factors Challenging the Market
- 4.4.2 Application
- 4.4.3 Product
- 4.4.4 France
- 4.4.5 Application
- 4.4.6 Product
- 4.4.7 Germany
- 4.4.8 Application
- 4.4.9 Product
- 4.4.10 U.K.
- 4.4.11 Application
- 4.4.12 Product
- 4.4.13 Spain
- 4.4.14 Application
- 4.4.15 Product
- 4.4.16 Italy
- 4.4.17 Application
- 4.4.18 Product
- 4.4.19 Rest-of-Europe
- 4.4.20 Application
- 4.4.21 Product
4.5 Asia-Pacific
- 4.5.1 Regional Overview
  - 4.5.1.1 Driving Factors for Market Growth
  - 4.5.1.2 Factors Challenging the Market
- 4.5.2 Application
- 4.5.3 Product
- 4.5.4 China
- 4.5.5 Application
- 4.5.6 Product
- 4.5.7 India
- 4.5.8 Application
- 4.5.9 Product
- 4.5.10 Japan
- 4.5.11 Application
- 4.5.12 Product
- 4.5.13 South Korea
- 4.5.14 Application
- 4.5.15 Product
- 4.5.16 Australia
- 4.5.17 Application
- 4.5.18 Product
- 4.5.19 Rest-of-Asia-Pacific
- 4.5.20 Application
- 4.5.21 Product
4.6 Latin America
- 4.6.1 Regional Overview
  - 4.6.1.1 Driving Factors for Market Growth
  - 4.6.1.2 Factors Challenging the Market
- 4.6.2 Application
- 4.6.3 Product
- 4.6.4 Brazil
- 4.6.5 Application
- 4.6.6 Product
- 4.6.7 Mexico
- 4.6.8 Application
- 4.6.9 Product
- 4.6.10 Rest-of-Latin America
- 4.6.11 Application
- 4.6.12 Product
4.7 Middle East and Africa
- 4.7.1 Regional Overview
  - 4.7.1.1 Driving Factors for Market Growth
  - 4.7.1.2 Factors Challenging the Market
- 4.7.2 Application
- 4.7.3 Product
- 4.7.4 U.A.E.
- 4.7.5 Application
- 4.7.6 Product
- 4.7.7 South Africa
- 4.7.8 Application
- 4.7.9 Product
- 4.7.10 Rest-of-Middle East and Africa
- 4.7.11 Application
- 4.7.12 Product

5 Markets - Competitive Benchmarking & Company Profiles

5.1 Next Frontiers
5.2 Competitive Landscape
- 5.2.1 Agilent Technologies, Inc.
  - 5.2.1.1 Overview
  - 5.2.1.2 Top Products
  - 5.2.1.3 Top Competitors
  - 5.2.1.4 Target Customers
  - 5.2.1.5 Key Personnel
  - 5.2.1.6 Analyst View
- 5.2.2 Azenta, Inc.
  - 5.2.2.1 Overview
  - 5.2.2.2 Top Products
  - 5.2.2.3 Top Competitors
  - 5.2.2.4 Target Customers
  - 5.2.2.5 Key Personnel
  - 5.2.2.6 Analyst View
- 5.2.3 BGI Group
  - 5.2.3.1 Overview
  - 5.2.3.2 Top Products
  - 5.2.3.3 Top Competitors
  - 5.2.3.4 Target Customers
  - 5.2.3.5 Key Personnel
  - 5.2.3.6 Analyst View
- 5.2.4 CD Genomics
  - 5.2.4.1 Overview
  - 5.2.4.2 Top Products
  - 5.2.4.3 Top Competitors
  - 5.2.4.4 Target Customers
  - 5.2.4.5 Key Personnel
  - 5.2.4.6 Analyst View
- 5.2.5 F. Hoffmann-La Roche Ltd
  - 5.2.5.1 Overview
  - 5.2.5.2 Top Products
  - 5.2.5.3 Top Competitors
  - 5.2.5.4 Target Customers
  - 5.2.5.5 Key Personnel
  - 5.2.5.6 Analyst View
- 5.2.6 Daicel Corporation
  - 5.2.6.1 Overview
  - 5.2.6.2 Top Products
  - 5.2.6.3 Top Competitors
  - 5.2.6.4 Target Customers
  - 5.2.6.5 Key Personnel
  - 5.2.6.6 Analyst View
- 5.2.7 Thermo Fisher Scientific Inc.
  - 5.2.7.1 Overview
  - 5.2.7.2 Top Products
  - 5.2.7.3 Top Competitors
  - 5.2.7.4 Target Customers
  - 5.2.7.5 Key Personnel
  - 5.2.7.6 Analyst View
- 5.2.8 Danaher Corporation
  - 5.2.8.1 Overview
  - 5.2.8.2 Top Products
  - 5.2.8.3 Top Competitors
  - 5.2.8.4 Target Customers
  - 5.2.8.5 Key Personnel
  - 5.2.8.6 Analyst View
- 5.2.9 Illumina, Inc.
  - 5.2.9.1 Overview
  - 5.2.9.2 Top Products
  - 5.2.9.3 Top Competitors
  - 5.2.9.4 Target Customers
  - 5.2.9.5 Key Personnel
  - 5.2.9.6 Analyst View
- 5.2.10 LGC Limited
  - 5.2.10.1 Overview
  - 5.2.10.2 Top Products
  - 5.2.10.3 Top Competitors
  - 5.2.10.4 Target Customers
  - 5.2.10.5 Key Personnel
  - 5.2.10.6 Analyst View
- 5.2.11 PacBio
  - 5.2.11.1 Overview
  - 5.2.11.2 Top Products
  - 5.2.11.3 Top Competitors
  - 5.2.11.4 Target Customers
  - 5.2.11.5 Key Personnel
  - 5.2.11.6 Analyst View
- 5.2.12 Revvity, Inc.
  - 5.2.12.1 Overview
  - 5.2.12.2 Top Products
  - 5.2.12.3 Top Competitors
  - 5.2.12.4 Target Customers
  - 5.2.12.5 Key Personnel
  - 5.2.12.6 Analyst View
- 5.2.13 Psomagen
  - 5.2.13.1 Overview
  - 5.2.13.2 Top Products
  - 5.2.13.3 Top Competitors
  - 5.2.13.4 Target Customers
  - 5.2.13.5 Key Personnel
  - 5.2.13.6 Analyst View
- 5.2.14 QIAGEN N.V.
  - 5.2.14.1 Overview
  - 5.2.14.2 Top Products
  - 5.2.14.3 Top Competitors
  - 5.2.14.4 Target Customers
  - 5.2.14.5 Key Personnel
  - 5.2.14.6 Analyst View
- 5.2.15 Takara Bio Inc.
  - 5.2.15.1 Overview
  - 5.2.15.2 Top Products
  - 5.2.15.3 Top Competitors
  - 5.2.15.4 Target Customers
  - 5.2.15.5 Key Personnel
  - 5.2.15.6 Analyst View

6 Research Methodology

6.1 Data Sources
- 6.1.1 Primary Data Sources
- 6.1.2 Secondary Data Sources
- 6.1.3 Data Triangulation
6.2 Market Estimation and Forecast

한글목차

목차

주요 요약

제1장 시장

제2장 용도

제3장 제품

제4장 지역

제5장 시장 - 경쟁 벤치마킹과 기업 개요

제6장 조사 방법